MEDNAX Announces Acquisition of Leading Tennessee Radiology Practice
This marks the Company’s eighth radiology services practice acquisition, further establishing MEDNAX Radiology Solutions as an industry leader, an innovator in health care informatics and a pioneer in telemedicine.
Associates in Diagnostic Radiology was established in 1974. Comprising
14 board certified and subspecialty-trained physicians, the practice
specializes in diagnostic imaging, interventional radiology,
neuroradiology, pediatric radiology, neuro-interventional radiology,
body imaging, musculoskeletal imaging and nuclear medicine. It provides
services to
“Our strategic partnership with
Upon completion of the transaction, MEDNAX’s affiliated radiologists will read more than 11.7 million studies annually.
This was a cash transaction and it is expected to be immediately accretive to earnings. No additional terms of the transaction were disclosed.
With this acquisition, eight physician group practices have become part
of
ABOUT
Certain statements and information in this press release may be
deemed to contain forward-looking statements within the meaning of the
Private Securities Litigation Reform Act of 1995, Section 27A of the
Securities Act of 1933, as amended, and Section 21E of the Securities
Exchange Act of 1934, as amended. Forward-looking statements may
include, but are not limited to, statements relating to our objectives,
plans and strategies, and all statements, other than statements of
historical facts, that address activities, events or developments that
we intend, expect, project, believe or anticipate will or may occur in
the future. These statements are often characterized by terminology such
as “believe”, “hope”, “may”, “anticipate”, “should”, “intend”, “plan”,
“will”, “expect”, “estimate”, “project”, “positioned”, “strategy” and
similar expressions, and are based on assumptions and assessments made
by MEDNAX’s management in light of their experience and their perception
of historical trends, current conditions, expected future developments
and other factors they believe to be appropriate. Any forward-looking
statements in this press release are made as of the date hereof, and
View source version on businesswire.com: https://www.businesswire.com/news/home/20181101005198/en/
Source:
MEDNAX, Inc.
Charles Lynch, 954-384-0175 ext. 5692
Vice
President, Strategy and Investor Relations
charles_lynch@mednax.com